Filtered By:
Condition: Atrial Fibrillation
Countries: Italy Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 65 results found since Jan 2013.
Prescriptive behavior of non-vitamin K oral anticoagulants in patients affected by atrial fibrillation in general practice
Biomed Pharmacother. 2023 Jun 21;165:115020. doi: 10.1016/j.biopha.2023.115020. Online ahead of print.ABSTRACTAtrial fibrillation (AF) is the most common cardiac arrhythmia worldwide and in recent years the pharmacological approach has been strongly implemented; in Italy, the prescription of the non-vitamin K oral anticoagulants (NOAC) was also extended to General Practitioners (GPs) since 2020. The aim of the present study was to investigate the GPs prescribing behaviour of NOACs. An observational study was performed by using the computerized medical record of 14 GPs in Sicily: patients affected by AF were selected and st...
Source: Biomedicine and pharmacotherapy = Biomedecine and pharmacotherapie - June 23, 2023 Category: Drugs & Pharmacology Authors: M Rottura S F A Drago A Molonia N Irrera S Marino R Scoglio L Orlando M Gigliotti De Fazio F Squadrito V Arcoraci E Imbalzano on the behalf of Audit & Research Messina Primary Care Group Source Type: research
Lipid profiles and atrial fibrillation in ischemic stroke patients treated with thrombectomy: experience from a tertiary Italian stroke hospital
CONCLUSION: Total cholesterol and all cholesterol-related measures were significantly lower in patients undergoing thrombectomy than in other stroke patients. Conversely, we found that AF was significantly high in patients with EVT, suggesting that hypercholesterolemia could be mainly linked to small-vessel occlusion stroke while large vessel occlusion (LVO) stroke could show different causes. AIS patients may have different pathogenesis and their understanding may improve enhance the discovery of specific and tailored preventive treatments.PMID:37221691 | DOI:10.2174/1871525721666230522124351
Source: Cardiovascular and Hematological Agents in Medicinal Chemistry - May 24, 2023 Category: Cardiology Authors: Maria Cristina Bravi Fabio Pilato Domenica Crupi Marilena Mangiardi Francesca Romana Pezzella Antonio Siniscalchi Enrico Cotroneo Luca Bertaccini Michele Alessiani Sabrina Anticoli Source Type: research
Sex differences in outcome after thrombectomy for acute ischemic stroke. A propensity score-matched study
CONCLUSIONS: Subject to the limitations of a non-randomized comparison, women with stroke due to LVO treated with mechanical thrombectomy had a better chance to achieve complete recanalization, and 3-month functional independence than men. The results could be driven by women who underwent combined treatment.PMID:35647312 | PMC:PMC9134778 | DOI:10.1177/23969873221091648
Source: Adv Data - June 1, 2022 Category: Epidemiology Authors: Ilaria Casetta Enrico Fainardi Giovanni Pracucci Valentina Saia Fabrizio Sallustio Valerio da Ros Sergio Nappini Patrizia Nencini Guido Bigliardi Sergio Vinci Francesco Grillo Sandra Bracco Rossana Tassi Mauro Bergui Paolo Cerrato Andrea Saletti Alessandr Source Type: research
Influence of atrial fibrillation subtypes on anticoagulant therapy in a high-risk older population: the FAI project
CONCLUSIONS: In a population-based survey, AF pattern was an independent predictor of OAC treatment. Paroxysmal AF is still perceived as carrying a lower risk of vascular events.PMID:35543807 | DOI:10.1007/s40520-022-02140-w
Source: Aging Clinical and Experimental Research - May 11, 2022 Category: Geriatrics Authors: Antonio Di Carlo Fabio Mori Domenico Consoli Leonardo Bellino Augusto Zaninelli Marzia Baldereschi Maria Grazia D'Alfonso Chiara Gradia Alessandro Cattarinussi Bruno Sgherzi Giovanni Pracucci Benedetta Piccardi Bianca Maria Polizzi Domenico Inzitari Natio Source Type: research
Anticoagulants for people hospitalised with COVID-19
CONCLUSIONS: When compared to a lower-dose regimen, higher-dose anticoagulants result in little to no difference in all-cause mortality and increase minor bleeding in people hospitalised with COVID-19 up to 30 days. Higher-dose anticoagulants possibly reduce pulmonary embolism, slightly increase major bleeding, may result in little to no difference in hospitalisation time, and may result in little to no difference in deep vein thrombosis, stroke, major adverse limb events, myocardial infarction, atrial fibrillation, or thrombocytopenia. Compared with no treatment, anticoagulants may reduce all-cause mortality but the evide...
Source: Cochrane Database of Systematic Reviews - March 4, 2022 Category: General Medicine Authors: Ronald Lg Flumignan Vinicius T Civile J éssica Dantas de Sá Tinôco Patricia If Pascoal Libnah L Areias Charbel F Matar Britta Tendal Virginia Fm Trevisani Álvaro N Atallah Luis Cu Nakano Source Type: research
